Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products


ECHAMP positions

Support the people's choice About homeopathic and anthroposophic medicinal products: Information for Members of the European Parliament 2019-2024 PDF (142.6 KB) Sep 07, 2020
Letter to the French Minister of Solidarity and Health Concerning the French debate on the reimbursement of homeopathic products PDF (150.3 KB) Jun 27, 2019
Open letter to the attention of Pedro Sánchez, the President of the Government of Spain Concerning the working document presented by María Luisa Carcedo, Minister of Health, Consumers and Social Services and Pedro Duque, Minister of Science, Innovation and Universities in the Instituto de Salud Carlos III on November the 13th, called "PLAN PARA LA PROTECCIÓN DE LA SALUD FRENTE A LAS PSEUDOTERAPIAS" PDF (444.6 KB) Nov 20, 2018
Safety of Homeopathic Medicinal Products (Art. 14 and Art. 16.2) –Calculation of First Safe Dilutions How to assess adequately the safety of homeopathic medicinal products? – Calculation of acceptable amounts based on the assessment of scientific data. PDF (908.7 KB) Oct 17, 2018
Determination of re-test dates of homeopathic intermediate dilutions is a matter of GMP PDF (770.6 KB) Oct 17, 2018
Flexibility Raw Material Suppliers Why raw material suppliers should be defined in the registration dossier only as examples? Flexibility is crucial for availability and without impact on good quality. PDF (798.0 KB) Oct 17, 2018
Open letter to the President of the Spanish Government Concerning the registration process in Spain PDF (225.6 KB) Jul 25, 2018
ECHAMP position on xEVMPD notifications for art. 14 products The pharmacovigilance requirements shall apply to homeopathic medicinal products, with the exception of homeopathic medicinal products registered further to the special, simplified registration procedure under Article 14(1) of Directive 2001/83/EC. PDF (266.8 KB) Jul 16, 2018
ECHAMP response: EASAC Statement on Homeopathic Products and Practices EASAC’s statement seeks to provide a scientific basis for policy making for homeopathic medicinal products in the EU; yet its assessment is based on incomplete knowledge of the current EU regulatory system for these products. Its review of the evidence for homeopathy depends on unreliable reports and studies and contains only second hand scientific analysis. PDF (605.4 KB) Sep 22, 2017
Justification for the practice of not fixing the supplier of certain raw materials in the homeopathic medicinal product dossier Fixing the supplier of raw materials in registration dossiers for homeopathic medicinal products does not in general add to the quality of the product. ECHAMP’s new position paper explains why registration dossiers should not generally require individual suppliers to be named. PDF (334.9 KB) Apr 24, 2015
Position paper on Braille Position paper on NtA, Volume 2A, Chapter 1, Rev. 4 from June 2013, section 3.3
News from ECHAMP

Subscribe here to receive regular information on developments affecting homeopathic and anthroposophic medicinal products in the EU.